Firefly Neuroscience, Inc. (AIFF) - Net Assets
Based on the latest financial reports, Firefly Neuroscience, Inc. (AIFF) has net assets worth $9.66 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.41 Million) and total liabilities ($2.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See how leveraged is Firefly Neuroscience, Inc.'s balance sheet to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $9.66 Million |
| % of Total Assets | 77.84% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 78.61 |
Firefly Neuroscience, Inc. - Net Assets Trend (2020–2024)
This chart illustrates how Firefly Neuroscience, Inc.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Firefly Neuroscience, Inc. stock valuation.
Annual Net Assets for Firefly Neuroscience, Inc. (2020–2024)
The table below shows the annual net assets of Firefly Neuroscience, Inc. from 2020 to 2024. Also explore AIFF net assets growth trend to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $-375.00K | -444.04% |
| 2023-12-31 | $109.00K | +105.16% |
| 2022-12-31 | $-2.11 Million | +29.96% |
| 2021-12-31 | $-3.01 Million | -286.81% |
| 2020-12-31 | $1.61 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Firefly Neuroscience, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7477848600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $86.71 Million | % |
| Total Equity | $-375.00K | 100.00% |
Firefly Neuroscience, Inc. Competitors by Market Cap
The table below lists competitors of Firefly Neuroscience, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Oncosil Medical Ltd
AU:OSL
|
$13.22 Million |
|
Cardiex Ltd
AU:CDX
|
$13.23 Million |
|
PT Jaya Bersama Indo Tbk
JK:DUCK
|
$13.23 Million |
|
Lisata Therapeutics Inc.
NASDAQ:LSTA
|
$13.25 Million |
|
AMD Industries Limited
NSE:AMDIND
|
$13.20 Million |
|
Swissnet AG
F:81D
|
$13.19 Million |
|
Audalia Resources Ltd
AU:ACP
|
$13.19 Million |
|
NextCell Pharma AB
ST:NXTCL
|
$13.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Firefly Neuroscience, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 109,000 to -375,000, a change of -484,000 (-444.0%).
- Net loss of 10,460,000 reduced equity.
- New share issuances of 4,308,000 increased equity.
- Other factors increased equity by 5,668,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.46 Million | -2789.33% |
| Share Issuances | $4.31 Million | +1148.8% |
| Other Changes | $5.67 Million | +1511.47% |
| Total Change | $- | -444.04% |
Book Value vs Market Value Analysis
This analysis compares Firefly Neuroscience, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.20 | $0.93 | x |
| 2021-12-31 | $-0.38 | $0.93 | x |
| 2022-12-31 | $-0.27 | $0.93 | x |
| 2023-12-31 | $0.01 | $0.93 | x |
| 2024-12-31 | $-0.06 | $0.93 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Firefly Neuroscience, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -9685.19%
- • Asset Turnover: 0.02x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-472.49%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 25.62% | 2.97% | 3.68x | 2.34x | $252.04K |
| 2021 | 0.00% | -13690.63% | 0.03x | 0.00x | $-4.08 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.58 Million |
| 2023 | -2388.07% | -522.69% | 0.19x | 24.23x | $-2.61 Million |
| 2024 | 0.00% | -9685.19% | 0.02x | 0.00x | $-10.42 Million |
Industry Comparison
This section compares Firefly Neuroscience, Inc.'s net assets metrics with peer companies in the Software - Application industry.
Industry Context
- Industry: Software - Application
- Average net assets among peers: $540,959,608
- Average return on equity (ROE) among peers: -330.53%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Firefly Neuroscience, Inc. (AIFF) | $9.66 Million | 25.62% | 0.28x | $13.22 Million |
| Adobe Systems Incorporated (ADBE) | $512.21 Million | 46.42% | 0.57x | $99.57 Billion |
| ADEIA CORP (ADEA) | $179.96 Million | 17.48% | 0.06x | $2.75 Billion |
| Automatic Data Processing Inc (ADP) | $3.41 Billion | 17.77% | 0.52x | $107.69 Billion |
| Autodesk Inc (ADSK) | $243.60 Million | 17.08% | 1.02x | $46.71 Billion |
| AudioEye Inc (AEYE) | $307.24K | -3117.67% | 13.61x | $71.03 Million |
| Agilysys Inc (AGYS) | $479.46 Million | 0.76% | 0.45x | $2.97 Billion |
| BlockchAIn Digital Infrastructure, Inc (AIB) | $9.98 Million | 52.24% | 0.32x | $43.69 Million |
| PowerFleet, Inc. (AIOT) | $45.60 Million | -8.86% | 0.38x | $397.31 Million |
| XIAO-I Corporation American Depositary Shares (AIXI) | $-8.98 Million | 0.00% | 0.00x | $8.14 Million |
About Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depres… Read more